Calcitonin, Osteocalcin and Osteopontin in Lung Cancer

ackground. Lung cancer markers are low levels of the hormone calcitonin in the blood, and high levels of proteins osteocalcin and osteopontin, connected to each other, reflect the processes of bone metastasis and have a predictive value. Objective: to evaluate blood levels of calcitonin, osteocalcin...

Full description

Bibliographic Details
Main Authors: Yu.V. Dumanskyi, V.A. Stepko, O.V. Syniachenko, H.S. Taktashov, O.A. Homozova
Format: Article
Language:English
Published: Publishing House Zaslavsky 2016-05-01
Series:Mìžnarodnij Endokrinologìčnij Žurnal
Subjects:
Online Access:http://iej.zaslavsky.com.ua/article/view/77795
id doaj-360153027a9a431485d91a63b88c9010
record_format Article
spelling doaj-360153027a9a431485d91a63b88c90102020-11-24T23:02:07ZengPublishing House ZaslavskyMìžnarodnij Endokrinologìčnij Žurnal2224-07212307-14272016-05-01124.76263010.22141/2224-0721.4.76.2016.7779577795Calcitonin, Osteocalcin and Osteopontin in Lung CancerYu.V. Dumanskyi0V.A. Stepko1O.V. Syniachenko2H.S. Taktashov3O.A. Homozova4Donetsk National Medical University named after M. Horkyi, Lyman, UkraineDonetsk National Medical University named after M. Horkyi, Lyman, UkraineDonetsk National Medical University named after M. Horkyi, Lyman, UkraineDonetsk National Medical University named after M. Horkyi, Lyman, UkraineDonetsk National Medical University named after M. Horkyi, Lyman, Ukraineackground. Lung cancer markers are low levels of the hormone calcitonin in the blood, and high levels of proteins osteocalcin and osteopontin, connected to each other, reflect the processes of bone metastasis and have a predictive value. Objective: to evaluate blood levels of calcitonin, osteocalcin and osteopontin, the factors determining them, the nature of relationships and prognostic role in bone metastasis at different variants of lung cancer. Materials and methods. The study included 86 patients with lung cancer aged 24 to 80 years (mean 58 years), among whom there were 84 % of men and 16 % of women. Central lung cancer occurred in 81 % of cases, peripheral — in 19 %. Small-cell lung cancer has been detected in 21 % of patients, non-small-cell — in 79 %, including adenocarcinoma — in 38 %, squamous-cell carcinoma — in 35 %, large-cell carcinoma — in 6 %. IIIA stage of neoplastic process was noted in 12 % of cases, IIIB — in 21 %, IV — in 67 %. Results. Lung cancer is accompanied by a decrease of bone-related hormone calcitonin in the blood of 20 % of patients on the background of increased concentrations of tumor markers osteocalcin and osteopontin (in 76 and 79 % of cases, respectively), which is closely associated with morphological variant (small- and non-small-cell), the stage and severity of pathological process, determines the development of compression syndrome, tumor invasion into the chest wall, metastasis in lymph nodes and bones, occurrence of chemoradiotherapy complications in the form of radiation pulmonary fibrosis, pulmonary hypertension and myelodepression, and indicators of osteocalcin- and osteopontinemia are inversely correlated with the duration of life of patients. Conclusions. In lung cancer, calcitonin, osteocalcin and osteopontin are the markers of the severity of the disease, reflect the metastasis of the tumor process in the skeleton and have a predictive value.http://iej.zaslavsky.com.ua/article/view/77795lung cancercalcitoninosteocalcinosteopontin
collection DOAJ
language English
format Article
sources DOAJ
author Yu.V. Dumanskyi
V.A. Stepko
O.V. Syniachenko
H.S. Taktashov
O.A. Homozova
spellingShingle Yu.V. Dumanskyi
V.A. Stepko
O.V. Syniachenko
H.S. Taktashov
O.A. Homozova
Calcitonin, Osteocalcin and Osteopontin in Lung Cancer
Mìžnarodnij Endokrinologìčnij Žurnal
lung cancer
calcitonin
osteocalcin
osteopontin
author_facet Yu.V. Dumanskyi
V.A. Stepko
O.V. Syniachenko
H.S. Taktashov
O.A. Homozova
author_sort Yu.V. Dumanskyi
title Calcitonin, Osteocalcin and Osteopontin in Lung Cancer
title_short Calcitonin, Osteocalcin and Osteopontin in Lung Cancer
title_full Calcitonin, Osteocalcin and Osteopontin in Lung Cancer
title_fullStr Calcitonin, Osteocalcin and Osteopontin in Lung Cancer
title_full_unstemmed Calcitonin, Osteocalcin and Osteopontin in Lung Cancer
title_sort calcitonin, osteocalcin and osteopontin in lung cancer
publisher Publishing House Zaslavsky
series Mìžnarodnij Endokrinologìčnij Žurnal
issn 2224-0721
2307-1427
publishDate 2016-05-01
description ackground. Lung cancer markers are low levels of the hormone calcitonin in the blood, and high levels of proteins osteocalcin and osteopontin, connected to each other, reflect the processes of bone metastasis and have a predictive value. Objective: to evaluate blood levels of calcitonin, osteocalcin and osteopontin, the factors determining them, the nature of relationships and prognostic role in bone metastasis at different variants of lung cancer. Materials and methods. The study included 86 patients with lung cancer aged 24 to 80 years (mean 58 years), among whom there were 84 % of men and 16 % of women. Central lung cancer occurred in 81 % of cases, peripheral — in 19 %. Small-cell lung cancer has been detected in 21 % of patients, non-small-cell — in 79 %, including adenocarcinoma — in 38 %, squamous-cell carcinoma — in 35 %, large-cell carcinoma — in 6 %. IIIA stage of neoplastic process was noted in 12 % of cases, IIIB — in 21 %, IV — in 67 %. Results. Lung cancer is accompanied by a decrease of bone-related hormone calcitonin in the blood of 20 % of patients on the background of increased concentrations of tumor markers osteocalcin and osteopontin (in 76 and 79 % of cases, respectively), which is closely associated with morphological variant (small- and non-small-cell), the stage and severity of pathological process, determines the development of compression syndrome, tumor invasion into the chest wall, metastasis in lymph nodes and bones, occurrence of chemoradiotherapy complications in the form of radiation pulmonary fibrosis, pulmonary hypertension and myelodepression, and indicators of osteocalcin- and osteopontinemia are inversely correlated with the duration of life of patients. Conclusions. In lung cancer, calcitonin, osteocalcin and osteopontin are the markers of the severity of the disease, reflect the metastasis of the tumor process in the skeleton and have a predictive value.
topic lung cancer
calcitonin
osteocalcin
osteopontin
url http://iej.zaslavsky.com.ua/article/view/77795
work_keys_str_mv AT yuvdumanskyi calcitoninosteocalcinandosteopontininlungcancer
AT vastepko calcitoninosteocalcinandosteopontininlungcancer
AT ovsyniachenko calcitoninosteocalcinandosteopontininlungcancer
AT hstaktashov calcitoninosteocalcinandosteopontininlungcancer
AT oahomozova calcitoninosteocalcinandosteopontininlungcancer
_version_ 1725637340165046272